http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100832870-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Y111-01007 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00 |
| filingDate | 2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2008-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100832870-B1 |
| titleOfInvention | Monoclonal Antibodies to SARS Coronavirus Nucleocapsid Proteins and Uses thereof |
| abstract | The present invention relates to monoclonal antibodies for diagnosis of SARS coronavirus. Specifically, the present invention immunized mice using recombinant SARS coronavirus nucleocapsid antigen as an immunogen, and produced hybridoma clones by cell fusion. Monoclonal antibodies produced from the hybridoma clones according to the present invention are excellent in sensitivity and specificity, and can be very useful for diagnosing and preventing SARS coronavirus infection.n n n n SARS coronavirus, nucleocapsid antigen, hybridoma clone, monoclonal antibody |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20220103577-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022216223-A1 |
| priorityDate | 2006-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 143.